Trials / Completed
CompletedNCT02472418
Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Crossover Study Evaluating Efficacy of DFN-15 in Patients With Migraine Headache With or Without Aura
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Crossover study of DFN-15 dose A versus DFN-15 dose B versus Placebo in the treatment of migraine headaches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DFN-15 Dose A (treatment A) | DFN-15 Dose A administered |
| DRUG | DFN-15 Dose B (treatment B) | DFN-15 Dose B administered |
| OTHER | Placebo (treatment C) | Placebo administered |
Timeline
- Start date
- 2015-06-05
- Primary completion
- 2015-12-01
- Completion
- 2016-05-05
- First posted
- 2015-06-15
- Last updated
- 2018-05-22
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02472418. Inclusion in this directory is not an endorsement.